Immunomet Therapeutics, Inc.
CIK 2109829 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Immunomet Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Feb 5, 2026 | D | 0002109829-26-000001 |